The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetes ...

FDA's new medical device quality management rules align U.S. standards with global requirements and give inspectors new ...

The FDA has issued serious 2026 alerts for glucose monitors, including a Class I recall for FreeStyle Libre 3. Learn how to verify your device and stay safe.

Insulet stock is up on fourth-quarter results ahead of consensus, with company leaders talking about talent, technology, and ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...

Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths ...

Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device – which is ...

This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...